MRI heart scan may forecast future for heart muscle disease patients

NCT ID NCT02352129

Completed Knowledge-focused Sponsor: Assistance Publique Hopitaux De Marseille Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 262 people with dilated cardiomyopathy, a condition where the heart muscle is weakened and enlarged. Researchers used a special MRI technique (T1 mapping) to measure scarring (fibrosis) in the heart. They wanted to see if the amount of scarring could predict serious events like death, heart transplant, or hospital stays over two years. The goal is to improve how doctors assess risk for these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to predict which patients with dilated cardiomyopathy are at higher risk of complications, helping doctors tailor treatment.
What could go wrong: This is an observational study, not a treatment trial. It may not change current care, and the findings might not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY, DILATED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dilated cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMYOPATHY, DILATED

Contacts and locations

Locations

Assistance Publique Hopitaux de Marseille

Marseille, 13354, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.